Radiotherapy, also known as radiation therapy, is used to slow cancer cell growth and shrink tumours. It destroys cancer cells' genetic material by utilising high-energy particles or waves such as x-rays, gamma rays, electron beams, or protons. It can be combined with other cancer treatments like surgery, chemotherapy, and immunotherapy to improve their efficacy. It is currently offered to patients based on their cancer type, tumour size and location, medical history, age, and medical conditions.
Market Trends in Radiotherapy:
One
of the key factors driving the Radiotherapy
Market is
the rising prevalence of cancer due to unhealthy dietary patterns, a lack of
physical activity, rising air pollution, and an increase in alcohol and tobacco
consumption. Furthermore, the risk of developing cancer increases dramatically
with age because the cellular repair is less effective in older people. As a
result, the growing geriatric population around the world is another
significant growth driver. Aside from that, the development of effective,
low-cost, and simple-to-use radiotherapy products is boosting the market growth.
Furthermore,
modern Radiotherapy Market techniques such as
three-dimensional (3D) conformal, intensity-modulated, and image-guided deliver
a lower dose to healthy tissues while a higher dose to the tumour. They also
improve organ-at-risk (OAR) sparing and give patients no physical sensation.
This is increasing their adoption in a variety of applications and settings in
chronic disease treatment, which is catalysing global demand for radiotherapy.
Furthermore, the market is expected to expand due to rising healthcare
expenditure in both emerging and developed economies.
The Radiotherapy Market is being driven by
an increase in the number of cancer patients, an increase in the geriatric
population, an increase in the adoption of radiotherapy devices and procedures
as a result of an increase in the number of radiotherapy awareness campaigns,
and technological advancements in radiotherapy devices. However, a shortage of
skilled personnel and difficulties in tumour visualisation limit market growth.
Furthermore, growth opportunities in emerging markets, as well as an increase
in cancer treatment demand, are expected to provide numerous opportunities for
market growth during the forecast period.
Accuray Incorporated, Varian Medical Systems, Inc.,
Elekta AB, Ion Beam Applications S.A., C.R. Bard, Inc., Isoray Medical, Inc.,
CIVCO Radiotherapy, Hitachi Ltd., Mevion Medical Systems, Inc., and ProTom
International, Inc. are major players in the global radiotherapy market.
Comments
Post a Comment